Cargando…

Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada

BACKGROUND: In Canada, epidermal growth factor receptor (EGFR) inhibitor therapies in advanced non-small cell lung cancer (NSCLC) were initially approved regardless of EGFR status. The purpose of this study is to characterise the use of second or later-line erlotinib therapy in Ontario, Canada from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perdrizet, Kirstin, Sutradhar, Rinku, Li, Qing, Liu, Ning, Earle, Craig C., Leighl, Natasha B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482335/ https://www.ncbi.nlm.nih.gov/pubmed/34659808 http://dx.doi.org/10.21037/jtd-21-804

Ejemplares similares

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
por: Dai, Wei Fang, et al.
Publicado: (2020)

Payment of overtime
por: Germain, P
Publicado: (1960)

Overtime and Compensatory Leave
Publicado: (1956)

Why do employees actively work overtime? The motivation of employees’ active overtime in China
por: Tan, Jinke, et al.
Publicado: (2023)

Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review
por: Benbrika, Soumia, et al.
Publicado: (2019)

The Effect of Worktime Control on Overtime Employees’ Mental Health and Work-Family Conflict: The Mediating Role of Voluntary Overtime
por: Yu, Jiaoyang, et al.
Publicado: (2022)

Where is the limit for overtime? Impacts of overtime on employees’ mental health and potential solutions: A qualitative study in China
por: Yu, Jiaoyang, et al.
Publicado: (2022)

Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability
por: Germonpré, Paul, et al.
Publicado: (2019)

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol
por: Dossa, Fahima, et al.
Publicado: (2018)

Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
por: Castagnari, Aldo
Publicado: (2008)

Perinatal Outcomes During the COVID-19 Pandemic in Ontario, Canada
por: Simpson, Andrea N., et al.
Publicado: (2021)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
por: Lu, Brandon, et al.
Publicado: (2023)

Risk of colorectal cancer among immigrants to Ontario, Canada
por: Paszat, Lawrence, et al.
Publicado: (2017)

Transfusion medicine: Overtime paradigm changes and emerging paradoxes
por: Garraud, O., et al.
Publicado: (2020)

Police Budgeting: Using Overtime as a Management Tool
por: Lira, Leonard, et al.
Publicado: (2022)

Fueling Work Engagement: The Role of Sleep, Health, and Overtime
por: Schleupner, Ricarda, et al.
Publicado: (2021)

Effect of overtime pancreaticoduodenectomy on the short-term prognosis of patients
por: Zhang, Jin-Zhu, et al.
Publicado: (2022)

Work hours and overtime of nurses working in Cambodian hospitals
por: Bae, Sung‐Heui, et al.
Publicado: (2021)

Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
por: Jun, Soojin, et al.
Publicado: (2023)

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
por: Kaseb, Ahmed O, et al.
Publicado: (2016)

Preeclampsia and Severe Maternal Morbidity During the COVID-19 Pandemic: A Population-Based Cohort Study in Ontario, Canada
por: Snelgrove, John W., et al.
Publicado: (2022)

Research on parking sharing strategies considering user overtime parking
por: Huang, Xin, et al.
Publicado: (2020)

College Football Overtime Outcomes: Implications for In-Game Decision-Making
por: Wilson, Rick L.
Publicado: (2020)

Association between overtime and depressive symptoms among Chinese employees
por: Liang, Yinyin, et al.
Publicado: (2023)

Enhanced detection rate of Mycoplasma genitalium in urine overtime by transcription-mediated amplification in comparison to real-time PCR
por: Adriaens, Nikki, et al.
Publicado: (2023)

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib
por: Melosky, B., et al.
Publicado: (2008)

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
por: He, Yayi, et al.
Publicado: (2016)

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
por: Lu, Shun, et al.
Publicado: (2018)

The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population‐based retrospective matched cohort analysis
por: Barbera, Lisa, et al.
Publicado: (2020)

Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab
por: Geiger, Caroline K., et al.
Publicado: (2023)

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
por: Gränsmark, Emma, et al.
Publicado: (2020)

Maintenance overtime policies in reliability theory: models with random working cycles
por: Nakagawa, Toshio, et al.
Publicado: (2015)

Context and Time Matter: Effects of Emotion and Motivation on Episodic Memory Overtime
por: Sun, Qing, et al.
Publicado: (2018)

Correction: Research on parking sharing strategies considering user overtime parking
por: Huang, Xin, et al.
Publicado: (2021)

145. Coping with the COVID-19 Pandemic Overtime Among Depressed Adolescents
por: Wilson, Tyia, et al.
Publicado: (2022)

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
por: Shin, Sangjin, et al.
Publicado: (2016)

Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma
por: Ohsawa, Manato, et al.
Publicado: (2023)

Association between end-of-life cancer care and immigrant status: a retrospective cohort study in Ontario, Canada
por: Chu, Anna, et al.
Publicado: (2021)

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients
por: Kim, Lucia, et al.
Publicado: (2017)

Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
por: Blomstrand, Hakon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dk0hvg1v32aoant3pfhjbg23sf